Exelixis News - EXEL

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Exelixis Inc EXEL NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.38 1.56% 24.71 23.87 24.78 24.42 24.33 00:00:07
more quote information »

Recent News

Date Time Source Heading
5/22/202017:21EDGARCurrent Report Filing (8-k)
5/13/202017:00BWExelixis Announces Results From COSMIC-021 Trial of..
5/12/202006:02EDGARCurrent Report Filing (8-k)
5/06/202016:05BWExelixis to Webcast Fireside Chats as Part of Virtual..
5/05/202016:17EDGARQuarterly Report (10-q)
5/05/202016:05BWExelixis Announces First Quarter 2020 Financial Results and..
4/30/202013:02EDGARConfidential Treatment Order (ct Order)
4/30/202013:02EDGARConfidential Treatment Order (ct Order)
4/21/202016:05BWExelixis to Release First Quarter 2020 Financial Results on..
4/20/202010:27DJNExelixis Shares Hit 52-Week High on Phase 3 Study Data
4/20/202007:50DJNBristol-Myers, Exelixis Phase 3 Kidney Cancer Study Meets..
4/20/202007:03EDGARCurrent Report Filing (8-k)
4/20/202006:59BWBristol Myers Squibb & Exelixis Announce Positive Topline..
4/09/202009:20EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/09/202009:17EDGARProxy Statement (definitive) (def 14a)
4/08/202016:05BWExelixis to Webcast Virtual Fireside Chat as Part of the..
3/25/202003:01BWExelixis Announces Partner Takeda Receives Approval in Japan..
3/02/202016:11EDGARCurrent Report Filing (8-k)
3/02/202016:05BWExelixis Announces George A. Scangos, Ph.D. to Retire From..
2/26/202016:05BWExelixis Announces Webcasts of Investor Conference..
2/25/202016:15EDGARAnnual Report (10-k)
2/25/202016:10EDGARCurrent Report Filing (8-k)
2/25/202016:06BWExelixis Announces First 100 Patients Enrolled in Phase 3..
2/25/202016:05BWExelixis Announces Fourth Quarter and Full Year 2019..
2/20/202017:06EDGARCurrent Report Filing (8-k)
2/12/202016:05BWExelixis to Release Fourth Quarter and Full Year 2019..
2/12/202015:27EDGARStatement of Ownership (sc 13g)
2/12/202008:00EDGARAmended Statement of Ownership (sc 13g/a)
2/10/202017:00BWExelixis Announces Encouraging Results for Cabozantinib in..
2/07/202011:19EDGARAmended Statement of Ownership (sc 13g/a)
2/06/202016:05BWExelixis Announces Webcasts of Investor Conference..
2/04/202011:55EDGARAmended Statement of Ownership (sc 13g/a)
1/29/202002:01BWExelixis Announces Partner Takeda Files New Drug Application..
1/24/202007:30BWExelixis Announces Results for Combination of Cabozantinib &..
1/13/202016:29EDGARCurrent Report Filing (8-k)
1/12/202016:00BWExelixis Outlines Key Priorities & Anticipated Milestones..
1/07/202016:05BWExelixis to Present at the 38th Annual J.P. Morgan..
1/07/202007:30BWExelixis Further Expands Prostate Cancer Cohort in Phase 1b..
12/19/201907:08EDGARCurrent Report Filing (8-k)
12/19/201907:00BWExelixis Enters into a Clinical Collaboration for Three..
12/13/201907:37DJNGenentech: Tecentriq/Cotellic/Zelboraf Combo Study Meets..
12/13/201901:02BWExelixis Announces Positive Results From IMspire150, the..
11/26/201916:06BWExelixis Announces Webcasts of Investor Conference..
11/12/201916:05BWExelixis to Present at the Stifel 2019 Healthcare Conference..
11/12/201908:02BWExelixis’ Partner Ipsen Announces Health Canada’s Approval..
11/07/201920:01BWExelixis’ Collaborator Daiichi Sankyo Announces Positive..
10/30/201916:16EDGARQuarterly Report (10-q)
10/30/201916:11EDGARCurrent Report Filing (8-k)
10/30/201916:05BWExelixis Announces Third Quarter 2019 Financial Results and..
10/16/201916:05BWExelixis to Release Third Quarter 2019 Financial Results on..
See more news about this stock »
Your Recent History
NASDAQ
EXEL
Exelixis
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200601 03:33:41